Barclays Maintains Equal-Weight on American Homes 4 Rent, Lowers Price Target to $35
Barclays analyst Rich Hightower maintains American Homes 4 Rent (NYSE:AMH) with a Equal-Weight and lowers the price target from $36 to $35.
Stocks · News reference
This Macerich Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Analysts upgraded MAC, INVH, CIEN, AMH and CADL, raising ratings and several price targets.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
RBC Capital Maintains Outperform on American Homes 4 Rent, Lowers Price Target to $35
UBS Maintains Neutral on American Homes 4 Rent, Lowers Price Target to $32
UBS analyst Michael Goldsmith maintains American Homes 4 Rent (NYSE:AMH) with a Neutral and lowers the price target from $35 to $32.
Evercore ISI Group Maintains Outperform on American Homes 4 Rent, Lowers Price Target to $37
Evercore ISI Group analyst Steve Sakwa maintains American Homes 4 Rent (NYSE:AMH) with a Outperform and lowers the price target from $38 to $37.
Candel Therapeutics to Present at the SITC 2026 Annual Meeting
Candel Therapeutics announced that it will present data from its aglatimagene besadenovec program in non-small cell lung cancer and clinical findings from its phase 1b trial of linoserpaturev in recurrent glioblastoma at the Society for Immunotherapy of Cancer's 41st Annual Meeting in November 2026. The presentations will showcase multi-omics analyses revealing immune activation and improved survival outcomes.
Candel Publishes Final Phase Of 2a Clinical Trial Results Of of Aglatimagene Besadenovec Plus Valacyclovir In Patients With Stage III/IV NSCLC Showing Inadequate Response To ICI.